Bryce D. Carmine
CIK 1430788 · EVP and Pres, Lilly Bio-Meds · last filed 2012-02-02
Bryce D. Carmine is an EVP and Pres, Lilly Bio-Meds who has filed 22 SEC Form 4 insider transactions across 1 company since 2009. The most recent filing, for LLY, was dated Feb 2, 2012. Across all open-market trades the lifetime net is −$2.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $174.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$174.60M
1
22
-$2.67M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LLY | EVP and Pres, Lilly Bio-Meds | 145,979 | $1196.03 | $174.60M | -$2.67M | 22 | 2012-02-02 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-02-02 | LLY | Mixed | +51,461 | -$1.45M | EDGAR |
| 2011-12-14 | LLY | Sell (S) | −5,787 | -$226.3K | EDGAR |
| 2011-11-14 | LLY | Sell (S) | −5,700 | -$214.0K | EDGAR |
| 2011-10-13 | LLY | Sell (S) | −5,700 | -$217.2K | EDGAR |
| 2011-09-14 | LLY | Mixed | −5,845 | -$204.7K | EDGAR |
| 2011-08-12 | LLY | Sell (S) | −5,700 | -$193.5K | EDGAR |
| 2011-07-13 | LLY | Mixed | −6,309 | -$213.1K | EDGAR |
| 2011-06-15 | LLY | Sell (S) | −5,700 | -$212.3K | EDGAR |
| 2011-05-13 | LLY | Sell (S) | −5,700 | -$217.8K | EDGAR |
| 2011-04-12 | LLY | Sell (S) | −5,700 | -$203.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.